Clinical Trials Browser

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

NCT04044872 2026-02-02

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Phase EARLY_PHASE1 Terminated

3 enrolled

Breast

Unilateral Breast Neoplasms, Cardiotoxicity

NCT05142358 2026-02-02

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Phase NA Completed

8 enrolled

BreastThoracic

Unilateral Breast Neoplasms, Lung Neoplasms, Neoplasms

NCT04481113 2026-01-29

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Phase 1 Completed

8 enrolled

Breast

Unilateral Breast Neoplasms

NCT07187726 2025-11-18

PRE-ACT-01

Phase NA Recruiting

724 enrolled

Breast

Unilateral Breast Neoplasms

NCT05726604 2023-06-09

RD3D4

Phase NA Unknown

15 enrolled

Breast

Leukocyte adhesion deficiency type 1, Unilateral Breast Neoplasms, Breast Neoplasms, Coronary Artery Disease, Radiation Injuries, Coronary Stenosis

NCT03514654 2021-05-18

MIAMI

Phase NA Completed

4 enrolled

Breast

Unilateral Breast Neoplasms, Breast Neoplasms

NCT02052102 2017-01-06

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Phase 2 Unknown

63 enrolled

Breast

Unilateral Breast Neoplasms, Breast Neoplasms, Radiation Injuries, Cardiotoxicity

NCT01496001 2015-10-06

Cosmetic and Functional Outcomes After Breast Conserving Surgery

Phase NA Completed

300 enrolled

Breast

Unilateral Breast Neoplasms, Breast Neoplasms

Clinical Trials

FourLight-3

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

PRE-ACT-01

RD3D4

MIAMI

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Cosmetic and Functional Outcomes After Breast Conserving Surgery